NFE2L2 and lung adenocarcinoma: Therefore, in order to explore the potential biomarkers in KEAP1/NRF2 mutated NSCLC, we performed integrated multi-omics approach by using A549 NSCLC cell lines and TCGA lung adenocarcinoma patients data.